A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Tucatinib
Related studies linked through entity extraction aliases.
A Safety, Tolerability, and Pharmacokinetic Study of Tucatinib in Healthy Japanese and Caucasian Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Tucatinib on Cardiac Repolarization in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2
Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1